Total Funding
51
2
Total FundingSeries A raised
Growth Score
-5 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
287510
Acerta Pharma provides drug discovery and development services for oncology and autoimmune diseases.
- Ahmed Hamdy: CEOPast Role: Pharmacyclics, CMO
- Sudha Khurana: Senior Scientist Clinical Development
About the Company
Acerta Pharma is focused on the development of covalent binding technology solutions to create therapies for cancer.
Acerta Pharma was acquired by AstraZeneca in February 2016.
Acerta Pharma was founded in 2013 and is based in San Carlos, California.
Women Founded
